Co-Diagnostics, Inc.
CODX
$0.56
$0.04639.01%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -71.09% | -91.70% | -94.70% | -97.10% | -95.61% |
| Total Other Revenue | 186.35% | -- | -- | -- | -- |
| Total Revenue | 57.16% | 25.24% | -44.91% | -80.09% | -91.25% |
| Cost of Revenue | 114.20% | 63.48% | 45.01% | -23.65% | -76.75% |
| Gross Profit | 23.37% | 8.24% | -70.69% | -90.86% | -93.61% |
| SG&A Expenses | -8.60% | -11.82% | 0.72% | -2.16% | 7.13% |
| Depreciation & Amortization | 9.61% | 3.72% | -7.87% | -4.08% | 11.91% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.27% | 2.86% | 14.27% | 8.10% | 5.72% |
| Operating Income | 3.88% | 1.31% | -37.14% | -268.44% | -540.34% |
| Income Before Tax | 28.54% | 24.92% | 1.45% | -102.21% | -418.17% |
| Income Tax Expenses | 139.99% | 118.09% | 94.00% | 39.73% | -864.21% |
| Earnings from Continuing Operations | 3.00% | 0.98% | -22.65% | -148.15% | -380.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.00% | 0.98% | -22.65% | -148.15% | -380.65% |
| EBIT | 3.88% | 1.31% | -37.14% | -268.44% | -540.34% |
| EBITDA | 4.29% | 1.47% | -39.17% | -302.34% | -483.39% |
| EPS Basic | 4.52% | 1.52% | -24.37% | -130.88% | -403.29% |
| Normalized Basic EPS | 6.32% | 2.11% | -41.46% | -255.72% | -544.46% |
| EPS Diluted | 4.87% | 2.08% | -24.20% | -130.31% | -413.36% |
| Normalized Diluted EPS | 6.32% | 2.11% | -41.46% | -249.94% | -570.39% |
| Average Basic Shares Outstanding | 2.05% | -0.57% | -4.16% | -7.79% | -7.34% |
| Average Diluted Shares Outstanding | 2.05% | -0.57% | -4.16% | -8.35% | -8.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
